SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-012577
Filing Date
2024-04-19
Accepted
2024-04-19 16:52:57
Documents
15
Period of Report
2024-04-19
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20240417_8k.htm   iXBRL 8-K 32652
2 EXHIBIT 3.1 ex_655800.htm EX-3.1 10823
  Complete submission text file 0001437749-24-012577.txt   183491

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wint-20240419.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240419_def.xml EX-101.DEF 11804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240419_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240419_pre.xml EX-101.PRE 12019
18 EXTRACTED XBRL INSTANCE DOCUMENT wint20240417_8k_htm.xml XML 2946
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 24858525
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)